8-KLeadership ChangesShareholder MattersExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Executive Changes (May 9, 2014)

Filed May 9, 2014For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences Corp. reports on the outcomes of their 2014 Annual Meeting of Stockholders. The primary focus is the approval of amendments to two key employee incentive programs: the Long-Term Stock Incentive Compensation Program and the 2001 Employee Stock Purchase Plan for International Employees. These amendments involve increasing the aggregate share limits available for awards and clarifying eligibility criteria for certain subsidiary representatives. Investors should note that the approval of these program amendments by stockholders indicates the company's continued commitment to aligning executive and employee interests with shareholder value through equity-based compensation. The increased share pools provide flexibility for future incentive grants, while the clarification on eligibility ensures broader participation within their global workforce. The filing also confirms the election of directors and the ratification of the independent auditor.

Key Highlights

  • 1Stockholders approved amendments to the Long-Term Stock Incentive Compensation Program, increasing the aggregate share limit by 2,000,000 shares to 50,900,000 shares.
  • 2The program's aggregate limit on restricted stock and restricted stock unit awards was increased by 1,000,000 shares.
  • 3The performance-based award feature, designed for Section 162(m) deductibility, will be extended through April 1, 2018.
  • 4Eligibility for the Long-Term Stock Program was clarified to include representative directors of foreign subsidiaries.
  • 5Stockholders approved amendments to the 2001 Employee Stock Purchase Plan for International Employees, increasing the aggregate share limit by 300,000 shares.
  • 6Eligibility for the International ESPP was also clarified to include representative directors of foreign subsidiaries.
  • 7The company reported final voting results for all proposals, including the election of directors, advisory vote on executive compensation, and ratification of the independent auditor.

Frequently Asked Questions

The key changes approved by stockholders include a 2,000,000 share increase in the aggregate share limit for awards, a 1,000,000 share increase in the limit for restricted stock and units, an extension of the performance-based award feature through April 1, 2018, and clarified eligibility for foreign subsidiary representative directors.

The increased share limits allow the company to issue more stock options and other equity-based awards to employees and executives. This can lead to increased dilution for existing shareholders over time. However, it also signals the company's intent to use equity compensation as a tool for talent retention and performance incentives.

Yes, Proposal 6, a stockholder proposal regarding action by written consent, was defeated. All other proposals, including the amendments to the incentive plans, director elections, executive compensation advisory vote, and auditor ratification, were approved.

The extension of the performance-based award feature through April 1, 2018, ensures that the company can continue to grant awards that are intended to be tax-deductible under Section 162(m) of the Internal Revenue Code. This provides flexibility in executive compensation design and can potentially preserve tax benefits for the company.